졸레드로네이트의 난소암 골전이 환자의 골성 통증 완화

키워드

참고문헌 (15)

1. Tiwari A, "Bone metastasis from ovarian cancer", J Cancer Res Ther, 3, pp.34~36 (2007)
2. Sansom HE, "Isolated bone metastasis from an endometroid ovarian carcinoma", Clin Radiol, 54, pp.135~137 (1999)
3. Kingston R, "Bone metastasis as the presenting complaint in ovarian carcinoma", Acta Obstet Gynecol Scand, 80, pp.669~670 (2001)
4. Coleman RE, "Management of bone metastases", Oncologist, 5, pp.463~470 (2000)
5. Hillner BE, "American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer", J Clin Oncol, 21, pp.4042~4057 (2003)
6. Polascik TJ, "Zoledronic acid in the management of metastatic bone disease", Ther Clin Risk Manag, 4, pp.261~268 (2008)
7. Berenson JR, "Recommendations for zoledronic acid treatment of patients with bone metastases", Oncologist, 10, pp.52~62 (2005)
8. Rose PG, "Metastatic patterns in histologic variants of ovarian cancer. An autopsy study", Cancer, 64, pp.1508~1513 (1989)
9. Abdul-Karim FW, "Bone metastasis from gynecologic carcinomas: a clinicopathologic study", Gynecol Oncol, 39, pp.108~114 (1990)
10. Janjan N, "Bone metastases: approaches to management", Semin Oncol, 28, pp.28~34 (2001)
11. Kohno N, "Treatment of breast cancer with bone metastasis: bisphosphonate treatment - current and future", Int J Clin Oncol, 13, pp.18~23 (2008)
12. Wilkinson AN, "Managing skeletal related events resulting from bone metastases", Br Med J, 337, pp.a2041~ (2008)
13. Lipton A, "Treatment of bone metastases and bone pain with bisphosphonates", Support Cancer Ther, 4, pp.92~100 (2007)
14. Powles T, "Randomized, placebocontrolled trial of clodronate in patients with primary operable breast cancer", J Clin Oncol, 20, pp.3219~3224 (2002)
15. Lipton A, "Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma", Cancer, 98, pp.962~969 (2003)

관련 논문AI추천